Author:
Boyden Thomas F.,Murthy Venkatesh L.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Applied Microbiology and Biotechnology,Histology
Reference50 articles.
1. Ghotbi AA, Kjaer A, Hasbak P. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging. Clin Physiol Funct Imaging. 2013. doi: 10.1111/cpf.12083 .
2. Caobelli F, Farina D, Pizzocaro C, Guerra UP. Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques? Eur J Nucl Med Mol Imaging. 2012;39:1970–2.
3. Nakazato R, Berman DS, Alexanderson E, Slomka P. Myocardial perfusion imaging with PET. Imaging Med. 2013;5:35–46.
4. Renaud JM, Mylonas I, McArdle B, Dowsley T, Yip K, Turcotte E, et al. Clinical interpretation standards and quality assurance for the multicenter PET/CT trial: 82Rb as an alternative radiopharmaceutical for myocardial imaging. J Nucl Med Off Publ Soc Nucl Med. 2013. doi: 10.2967/jnumed.112.117515 .
5. Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29:193–207.